EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Microbiota in liver carcinogenesis: Illuminating the complex relationship

Natthaya Chuaypen, Thasinas Dissayabutra, Jasmohan S Bajaj

Best Practice & Research Clinical Gastroenterology · 2026-08 · 83 · 102144

DOI: 10.1016/j.bpg.2026.102144 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Best Practice & Research Clinical Gastroenterology, 2026-08. Verfasst von Natthaya Chuaypen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center of Excellence in Kidney-Liver-Microbiota, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Liver Cirrhosis, Gastrointestinal Microbiome. Die Arbeit nennt 146 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CSRD VA, NIAAA NIH HHS, National Institute on Alcohol Abuse and Alcoholism.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) develops predominantly in patients with cirrhosis, yet the biological mechanisms underlying the transition from cirrhosis to malignancy remain incompletely understood. Increasing evidence suggests that the oral-gut-liver axis contributes to this process through coordinated interactions among oral and intestinal microbiota, the epithelial barrier, the immune system, and the liver. While previous reviews have primarily focused on gut dysbiosis in cirrhosis and its complications, emerging evidence indicates that microbiome-associated alterations actively contribute to hepatocarcinogenesis. In this review, we propose a transition-state model in which disruption of the oral-gut-liver axis promotes progression from cirrhosis to HCC through functional microbiome insufficiency, epithelial barrier dysfunction, microbial translocation, inflammatory remodeling, and immune dysregulation. We emphasize that disruption of microbial metabolic functions, including reduced butyrate biosynthesis, bile acid remodeling, altered tryptophan metabolism, and enrichment of virulence-associated pathways may be more biologically relevant than taxonomic changes alone. We further discuss emerging biomarkers representing distinct domains of the gut-liver axis, including butyryl-CoA:acetate CoA-transferase (BCoAT) as a marker of microbial function, intestinal fatty acid-binding protein (I-FABP) as a marker of epithelial injury, and lipopolysaccharide-binding protein (LBP) as a marker of microbial translocation and endotoxemia. Finally, we discuss the translational implications of integrating microbiome-derived functional biomarkers with immune and clinical profiling for biological risk stratification, early detection, and precision hepatology as well as therapeutic strategies based on microbiome modulation. This framework shifts the focus from descriptive dysbiosis toward mechanistic host-microbiome interactions, highlights the oral-gut-liver axis as an active contributor to hepatocarcinogenesis, and provides a conceptual foundation for future microbiome-informed surveillance, risk stratification, and therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularLiver CirrhosisGastrointestinal MicrobiomeLiverCarcinogenesisHumansDysbiosisDisease ProgressionIntestinal Barrier FunctionBacterial TranslocationAnimals

Stichwörter der Autor:innen

BiomarkersCirrhosisFunctional microbiome insufficiencyHepatocellular carcinomaOral–gut–liver axis

Autor:innen und Institutionen

  • Center of Excellence in Kidney-Liver-Microbiota, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Department of Medicine, Virginia Commonwealth University, Richmond, VA, USA; Department of Medicine, Richmond VA Medical Center, Richmond, VA, USA. Electronic address: Jasmohan.bajaj@vcuhealth.org.

Förderung

  • CSRD VA
  • NIAAA NIH HHS
  • National Institute on Alcohol Abuse and Alcoholism
  • US Department of Veterans Affairs
  • Chulalongkorn University

Zitieren

APA

Chuaypen, N., Dissayabutra, T., & Bajaj, J. S. (2026). Microbiota in liver carcinogenesis: Illuminating the complex relationship. Best Practice & Research Clinical Gastroenterology, 83, 102144. https://doi.org/10.1016/j.bpg.2026.102144

Vancouver

Chuaypen N, Dissayabutra T, Bajaj JS. Microbiota in liver carcinogenesis: Illuminating the complex relationship. Best Practice & Research Clinical Gastroenterology. 2026;83:102144. doi:10.1016/j.bpg.2026.102144

BibTeX
@article{Chuaypen2026,
  author = {Chuaypen, Natthaya and Dissayabutra, Thasinas and Bajaj, Jasmohan S},
  title = {Microbiota in liver carcinogenesis: Illuminating the complex relationship},
  journal = {Best Practice & Research Clinical Gastroenterology},
  year = {2026},
  volume = {83},
  pages = {102144},
  doi = {10.1016/j.bpg.2026.102144}
}
Kostenlos starten →